Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Filings indexed 671 across all filing types
Latest filing 2022-09-22 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) ..
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates by shareholders. It is addressed to the stock exchange and provides details of the lost share certificates. This is a regulatory announcement related to shareholding records but does not constitute a financial report, earnings release, or management information. It is not a report publication announcement or certification. The content fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories.
2022-09-22 English
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Presentation for September 2022 for ....
Regulatory Filings
2022-09-22 English
In connection with the meeting of the Unsecured Creditors of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking ....
Regulatory Filings
2022-09-02 English
Submission of voting results of Voting at the Meeting and Remote E-Voting and under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for ....
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report on the voting results of a shareholders meeting, specifically related to the approval of a composite scheme of amalgamation and arrangement. It includes voting statistics, quorum details, and a scrutinizer's report pursuant to the Companies Act, 2013 and SEBI regulations. The presence of detailed voting results, the mention of the scrutinizer's report, and the focus on shareholder voting outcomes indicate this is an official declaration of voting results from a general meeting. It is not a full annual report, earnings release, or management discussion, nor is it a proxy solicitation or a regulatory filing. The document fits the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2022-09-02 English
In connection with the meeting of the Secured Creditors of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking ....
Regulatory Filings
2022-09-02 English
In connection with the meeting of the Equity Shareholders of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking ....
Regulatory Filings
2022-09-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.